Allianz SE (ALIZF) Financials Nov 14, 2014, 8:10
Allianz SE (ALIZF) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Allianz SE
Fiscal year is January-December. All values EUR millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 86.99B 91.69B 93.23B 98.03B 98.95B
Premiums Earned 59.86B 63.34B 63.67B 66.05B 66.63B
Total Investment Income 15.05B 15.79B 16.79B 17.02B 16.59B
Realized Gains (Losses) 3.2B 2.14B 1.85B 3.43B 3.56B
Other Operating Income 8.88B 10.42B 10.92B 11.53B 12.18B
Losses, Claims & Reserves 55.21B 59.97B 59.86B 63.23B 61.79B
Losses, Benefits & Adjustments 45.65B 46.12B 48.88B 48.95B 47.48B
2009 2010 2011 2012 2013 5-year trend
Selling, General & Admin. Expenses & Other 22.05B 22.8B 23.44B 23.45B 24.15B
Selling, General & Admin. Expenses 20.54B 20.93B 20.88B 21.48B 22.19B
Other Selling, General & Admin. Expense 8.99B 8.97B 8.98B 8.76B 8.89B
Underwriting & Commissions 11.55B 11.96B 11.91B 12.73B 13.3B
Other Operating Expense 1.51B 1.86B 2.56B 1.97B 1.96B
Operating Income Before Interest Expense 9.74B 8.93B 9.93B 11.35B 13.01B
Interest Expense, Net of Interest Capitalized 1.48B 1.41B 1.49B 1.48B 1.32B
Interest Expense (excl. Interest Capitalized) 1.48B 1.41B 1.49B 1.48B 1.32B
Interest Capitalized 0 0 0 0 0
Operating Income After Interest Expense 8.25B 7.52B 8.44B 9.87B 11.69B
Non-Operating Income (Expense) 5M 577M (61M) (95M) (1.43B)
Miscellaneous Non Operating Expense (81M) 577M (61M) (95M) (1.43B)
Equity in Affiliates (Pretax) 86M - - - -
Unusual Expense 2.93B 1.12B 3.83B 1.2B 781M
Pretax Income 5.33B 6.98B 4.55B 8.57B 9.49B
Income Taxes 588M 1.96B 2.04B 3.16B 3.3B
Income Tax - Current - Domestic (299M) 198M 516M 3.32B 2.9B
Income Tax - Current - Foreign 1.49B 1.72B 1.28B - -
Income Tax - Deferred - Domestic (500M) (89M) (188M) (163M) 401M
Income Tax - Deferred - Foreign (107M) 132M 433M - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 190M 301M 146M 159M
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 4.74B 5.21B 2.8B 5.56B 6.34B
Minority Interest Expense 48M 156M 259M 327M 348M
Net Income 4.69B 5.05B 2.55B 5.23B 6B
Extraordinaries & Discontinued Operations (395M) 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations (395M) 0 0 0 0
Net Income After Extraordinaries 4.3B 5.05B 2.55B 5.23B 6B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 4.69B 5.05B 2.55B 5.23B 6B
EPS (Basic) 9.53 11.20 5.63 11.56 13.23
Basic Shares Outstanding 450.85M 451.28M 451.76M 452.67M 453.3M
EPS (Diluted) 9.50 11.12 5.48 11.48 13.05
Diluted Shares Outstanding 452.39M 452.5M 453.13M 452.77M 453.49M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...
Continue Reading
Pedaling for Purpose: A Journey That Sparked a Movement What started as a lone journey across America's roads has turned into a celebrated movement to honor those who often go unnoticed. Back in 2009, Shawn Anderson embarked on an unusual journey. Armed only with a bicycle and determination, he pedaled from San Francisco to Boston—over 4,000 miles in just 90 days. It...
Continue Reading
Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...
Continue Reading
Mixing Hockey and Hamburgers: The Peltz Way You'd think a guy like Nelson Peltz wouldn't be juggling hockey sticks and hamburgers at the same time, but here we are. The man, a mogul of sorts with Trian Fund Management, is hopping onto a board seat with a New York hockey company and, oh, by the way, throwing a non-binding $7.35-a-share cash proposal to snatch up Wendy's, a...
Continue Reading
Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...
Continue Reading
Decades of Trust in Cancer Care Virginia Cancer Specialists isn't just another name in the sea of healthcare providers. That pride they're feeling? Well, they've got every right to it. Just slapped their physicians' names all over the latest Washingtonian's Top Doctors list for 2026. And this isn’t some under-the-table handshake deal. No, this list is shaped by peer...
Continue Reading
There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....
Continue Reading
The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...
Continue Reading
From Humble Beginnings to High Achiever Alright, let's touch base on Canada's tech landscape for a moment. Infoya's leap into Deloitte's 2026 Technology Fast 50 isn't just a pat on the back—it's a flashing neon sign of what raw ambition mixed with a pinch of AI can cook up for you. They've banked a whopping 665% revenue growth from 2022 to 2025. Not bad for a company...
Continue Reading
Wine Industry Shifts Gears Well, here's a twist that might just shake up the wine racks. C. Mondavi & Family, from the historic Charles Krug estate, is aligning with Missing Thorn—a name gaining traction in the non-alcoholic wine scene. It’s a move that not only raises eyebrows but could also expand your wine-tasting options come your next sober night out. So what...
Continue Reading
Top 5 Most Recently Viewed Articles
Infortar's Share Buyback Strategy Infortar is actively engaging in a share buyback program on the Nasdaq Tallinn Stock Exchange. This initiative reflects a strategic approach towards securing and stabilizing their market presence. During a recent period, Infortar made notable acquisitions of its own shares, an activity that signals confidence in its long-term value....
Continue Reading
Cisco Sets New Milestone with 52-Week High Cisco Systems Inc (NASDAQ: CSCO) has achieved a remarkable milestone as its shares soared to a 52-week high of $60.23. This surge reflects the company's impressive growth trajectory and consistent performance over the past year. With a current market capitalization of $239.6 billion, analysts suggest that the stock may be...
Continue Reading
Understanding the Disclosure Process for Life Science REIT Plc The disclosure of relevant securities for companies listed on the stock exchange is crucial for maintaining transparency and regulatory compliance. One important example is the recent public opening position disclosure by Life Science REIT Plc, a notable name in the real estate investment trust sector. This...
Continue Reading
Opportunities in Oversold Energy Stocks In the energy sector, there is often potential for long-term gains hidden within oversold stocks. When a stock exhibits an oversold condition, it's usually an indicator that investor sentiment has driven the price down more than justified by the company's fundamentals. This presents a buy opportunity for savvy investors....
Continue Reading
Terranet's Technology Development Progress Report Recently, Terranet has shared updates with stakeholders regarding its advancements in technology during the second quarter. The company has begun the initial integration of its system into a vehicle, which will lead to an expanded testing phase that will be reported back to the market. The analyses confirm that the ongoing...
Continue Reading